Procedures of Data and Safety Monitoring Committees
- 1 February 2001
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 141 (2), 289-294
- https://doi.org/10.1067/mhj.2001.113082
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Postmenopausal Hormone Therapy Increases Risk for Venous Thromboembolic Disease: The Heart and Estrogen/progestin Replacement StudyAnnals of Internal Medicine, 2000
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Effects of Lowering Average or Below-Average Cholesterol Levels on the Progression of Carotid AtherosclerosisCirculation, 1998
- Venous Thromboembolic Events Associated With Hormone Replacement TherapyPublished by American Medical Association (AMA) ,1997
- Fetal Hemoglobin in Sickle Cell Anemia: Determinants of Response to HydroxyureaBlood, 1997
- The PACK Trial: Morbidity and Mortality Effects of KetanserinVascular Medicine, 1996
- Effects of the Early Administration of Enalapril on Mortality in Patients with Acute Myocardial InfarctionNew England Journal of Medicine, 1992
- Policies for study monitoring and interim reporting of results.Journal of Clinical Oncology, 1987
- A case report of data monitoring experience: The nocturnal oxygen therapy trialControlled Clinical Trials, 1982
- Continuous or Nocturnal Oxygen Therapy in Hypoxemic Chronic Obstructive Lung DiseaseAnnals of Internal Medicine, 1980